Cargando…
LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence
INTRODUCTION: Methamphetamine dependence is a growing public health concern. There is currently no pharmacotherapy approved for methamphetamine dependence. Lisdexamfetamine (LDX) dimesylate, used in the treatment of attention-deficit hyperactivity disorder and binge eating disorder, has potential as...
Autores principales: | Ezard, Nadine, Dunlop, Adrian, Hall, Michelle, Ali, Robert, McKetin, Rebecca, Bruno, Raimondo, Phung, Nghi, Carr, Andrew, White, Jason, Clifford, Brendan, Liu, Zhixin, Shanahan, Marian, Dolan, Kate, Baker, Amanda L, Lintzeris, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059315/ https://www.ncbi.nlm.nih.gov/pubmed/30030312 http://dx.doi.org/10.1136/bmjopen-2017-020723 |
Ejemplares similares
-
Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study
por: Ezard, Nadine, et al.
Publicado: (2021) -
Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence
por: Ezard, Nadine, et al.
Publicado: (2016) -
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal
por: Acheson, Liam S., et al.
Publicado: (2022) -
Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes
por: Stuart, Alexandra, et al.
Publicado: (2017) -
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study
por: Larance, Briony, et al.
Publicado: (2020)